|
1
|
Chen H, Bai C and Wang X: The value of the
lipopolysaccharide-induced acute lung injury model in respiratory
medicine. Expert Rev Respir Med. 4:773–783. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Avecillas JF, Freire AX and Arroliga AC:
Clinical epidemiology of acute lung injury and acute respiratory
distress syndrome: Incidence, diagnosis, and outcomes. Clin Chest
Med. 27:549–557. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bellani G, Laffey JG, Pham T, Fan E,
Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley
DF, et al: Epidemiology, patterns of care, and mortality for
patients with acute respiratory distress syndrome in intensive care
units in 50 countries. JAMA. 315:788–800. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jongerius I, Porcelijn L, van Beek AE,
Semple JW, van der Schoot CE, Vlaar APJ and Kapur R: The role of
complement in transfusion-related acute lung injury. Transfus Med
Rev. 33:236–242. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Murray DD, Itenov TS, Sivapalan P, Eklöf
JV, Holm FS, Schuetz P and Jensen JU: Biomarkers of acute lung
injury the individualized approach: For phenotyping, risk
stratification and treatment surveillance. J Clin Med.
8(1163)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liu H, Yu X, Yu S and Kou J: Molecular
mechanisms in lipopolysaccharide-induced pulmonary endothelial
barrier dysfunction. Int Immunopharmacol. 29:937–946.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lei J, Wei Y, Song P, Li Y, Zhang T, Feng
Q and Xu G: Cordycepin inhibits LPS-induced acute lung injury by
inhibiting inflammation and oxidative stress. Eur J Pharmacol.
818:110–114. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nova Z, Skovierova H and Calkovska A:
Alveolar-capillary membrane-related pulmonary cells as a target in
endotoxin-induced acute lung injury. Int J Mol Sci.
20(831)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Reiss LK, Uhlig U and Uhlig S: Models and
mechanisms of acute lung injury caused by direct insults. Eur J
Cell Biol. 91:590–601. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rebetz J, Semple JW and Kapur R: The
pathogenic involvement of neutrophils in acute respiratory distress
syndrome and transfusion-related acute lung injury. Transfus Med
Hemother. 45:290–298. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang Y, Zhang M, Zhong M, Suo Q and Lv K:
Expression profiles of miRNAs in polarized macrophages. Int J Mol
Med. 31:797–802. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen X, Slack FJ and Zhao H: Joint
analysis of expression profiles from multiple cancers improves the
identification of microRNA-gene interactions. Bioinformatics.
29:2137–2145. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wei Y, Nazari-Jahantigh M, Chan L, Zhu M,
Heyll K, Corbalán-Campos J, Hartmann P, Thiemann A, Weber C and
Schober A: The microRNA-342-5p fosters inflammatory macrophage
activation through an Akt1- and microRNA-155-dependent pathway
during atherosclerosis. Circulation. 127:1609–1619. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ono K, Kuwabara Y and Han J: MicroRNAs and
cardiovascular diseases. FEBS J. 278:1619–1633. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ro S, Park C, Young D, Sanders KM and Yan
W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res.
35:5944–5953. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mallory AC and Vaucheret H: MicroRNAs:
Something important between the genes. Curr Opin Plant Biol.
7:120–125. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Meng L, Chen Z, Jiang Z, Huang T, Hu J,
Luo P, Zhang H, Huang M, Huang L, Chen Y, et al: MiR-122-5p
suppresses the proliferation, migration, and invasion of gastric
cancer cells by targeting LYN. Acta Biochim Biophys Sin (Shanghai).
521:49–57. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ding Z, Lin J, Sun Y, Cong S, Liu S, Zhang
Y, Chen Q and Chen J: miR-122-5p negatively regulates the
transforming growth factor-β/Smad signaling pathway in skeletal
muscle myogenesis. Cell Biochem Funct. 382:231–238. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Yang Z, Wu W, Ou P, Wu M, Zeng F, Zhou B
and Wu S: MiR-122-5p knockdown protects against APAP-mediated liver
injury through up-regulating NDRG3. Mol Cell Biochem.
476:1257–1267. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ge Y, Tu W, Li J, Chen X, Chen Y, Xu Y, Xu
Y, Wang Y and Liu Y: MiR-122-5p increases radiosensitivity and
aggravates radiation-induced rectal injury through CCAR1. Toxicol
Appl Pharmacol. 399(115054)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lu Z, Feng H, Shen X, He R, Meng H, Lin W
and Geng Q: MiR-122-5p protects against acute lung injury via
regulation of DUSP4/ERK signaling in pulmonary microvascular
endothelial cells. Life Sci. 256(117851)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yazdi AS and Ghoreschi K: The
interleukin-1 family. Adv Exp Med Biol. 941:21–29. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lin SC, Lo YC and Wu H: Helical assembly
in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature.
465:885–890. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bui CB, Kolodziej M, Lamanna E, Elgass K,
Sehgal A, Rudloff I, Schwenke DO, Tsuchimochi H, Kroon MAGM, Cho
SX, et al: Interleukin-1 receptor antagonist protects newborn mice
against pulmonary hypertension. Front Immunol.
10(1480)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sun D, Zhao M, Ma D, Liao S and Di C:
Protective effect of interleukin-1 receptor antagonist on oleic
acid-induced lung injury. Chin Med J (Engl). 109:522–526.
1996.PubMed/NCBI
|
|
27
|
Zhou H, Wang X and Zhang B: Depression of
lncRNA NEAT1 antagonizes LPS-evoked acute injury and inflammatory
response in alveolar epithelial cells via HMGB1-RAGE signaling.
Mediators Inflamm. 2020(8019467)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gill SE, Yamashita CM and Veldhuizen RA:
Lung remodeling associated with recovery from acute lung injury.
Cell Tissue Res. 367:495–509. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yang G and Zhao Y: MicroRNA-490-3p
inhibits inflammatory responses in LPS-induced acute lung injury of
neonatal rats by suppressing the IRAK1/TRAF6 pathway. Exp Ther Med.
21(152)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li P, Yao Y, Ma Y and Chen Y: MiR-150
attenuates LPS-induced acute lung injury via targeting AKT3. Int
Immunopharmacol. 75(105794)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Suo T, Chen GZ, Huang Y, Zhao KC, Wang T
and Hu K: miRNA-1246 suppresses acute lung injury-induced
inflammation and apoptosis via the NF-κB and Wnt/β-catenin signal
pathways. Biomed Pharmacother. 108:783–791. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ma W, Zhao X, Xue N, Gao Y and Xu Q: The
LINC01410/miR-122-5p/NDRG3 axis is involved in the proliferation
and migration of osteosarcoma cells. IUBMB Life. 73:705–717.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fan YC, Lee KD and Tsai YC: Roles of
interleukin-1 receptor antagonist in prostate cancer progression.
Biomedicines. 8(602)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rocha GA, Guerra JB, Rocha AM, Saraiva IE,
da Silva DA, de Oliveira CA and Queiroz DM: IL1RN polymorphic gene
and cagA-positive status independently increase the risk of
noncardia gastric carcinoma. Int J Cancer. 115:678–683.
2005.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang K, Liu H, Liu J, Wang X, Teng L,
Zhang J, Liu Y, Yao Y, Wang J, Qu Y, et al: IL1RN mediates the
suppressive effect of methionine deprivation on glioma
proliferation. Cancer Lett. 54:146–157. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Worst TS, Reiner V, Gabriel U, Weiß C,
Erben P, Martini T and Bolenz C: IL1RN and KRT13 expression in
bladder cancer: Association with pathologic characteristics and
smoking status. Adv Urol. 2014(184602)2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Li P, Zhou Y, Goodwin AJ, Cook JA,
Halushka PV, Zhang XK, Wilson CL, Schnapp LM, Zingarelli B and Fan
H: Fli-1 governs pericyte dysfunction in a murine model of sepsis.
J Infect Dis. 218:1995–2005. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Niu X, Zang L and Li W, Xiao X, Yu J, Yao
Q, Zhao J, Ye Z, Hu Z and Li W: Anti-inflammatory effect of yam
glycoprotein on lipopolysaccharide-induced acute lung injury via
the NLRP3 and NF-κB/TLR4 signaling pathway. Int Immunopharmacol.
81(106024)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Li S, Zhang Y, Guan Z, Li H, Ye M, Chen X,
Shen J, Zhou Y, Shi ZL, Zhou P and Peng K: SARS-CoV-2 triggers
inflammatory responses and cell death through caspase-8 activation.
Signal Transduct Target Ther. 5(235)2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yang L, Zhang Z, Zhuo Y, Cui L, Li C, Li
D, Zhang S, Cui N, Wang X and Gao H: Resveratrol alleviates
sepsis-induced acute lung injury by suppressing inflammation and
apoptosis of alveolar macrophage cells. Am J Transl Res.
10:1961–1975. 2018.PubMed/NCBI
|
|
43
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104.
1999.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Fan Y and Bergmann A: The
cleaved-caspase-3 antibody is a marker of caspase-9-like DRONC
activity in Drosophila. Cell Death Differ. 17:534–539.
2010.PubMed/NCBI View Article : Google Scholar
|
